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Abstract: Today, additive manufacturing (AM) is implemented in medical industry and profoundly revolutionizes this area. 
This approach consists of producing parts by additions of layers of successive materials and offers advantages in terms of 
rapidity, complexity of parts, competitive costs that can be exploited and can lead to a significant advancement in biological 
research. Everything becomes technically feasible and gives way to a “techno-centered” approach. Many parameters must 
be controlled in this field, so it is necessary to be guided for the development of such a product. This article aims to present 
a state of the art of existing design methodologies focused on AM to create medical devices. Finally, a development method 
is proposed that consists of producing vascular geometry using AM, based on patient data, designed for cell culture in vitro 
studies.
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1. Introduction
In recent years, additive manufacturing (AM) offers 
significant benefits for a wide range of applications, 
especially in the medical sector. Among these applications, 
bioprinting has emerged, covering printing of biological 
cells as well as printing of materials (e.g. polymer, ceramic 
or even metal) that are used for cellular culture. Thus, AM 
can be used to create vascular geometries, designed for 
in vitro studies. This approach allows to better understand 
the physiopathology of many diseases such as sickle cell 
disease (SCD), the most common severe monogenic 
disorders in the world with 275,000 cases detected each 
year in newborns[1,2].
It is due to a mutation in the hemoglobin (Hb) beta-
globin gene leading to the production of abnormal 
HbS. The change in molecular structure allows HbS in 
the deoxygenated state to form polymers that promote 
Hb polymerization, red blood cell (RBC) membrane 
damage, decreased RBC deformability, intravascular, and 
extravascular hemolysis. These RBC abnormalities lead 
to vessel inflammation, vaso-occlusion, and ultimately 
organ injury[3].
About 114,000 SCD patients die every year from 
complications[4]. Among them, cerebral vasculopathy 
is responsible for stroke all lifelong. However, the 
physiopathology of cerebral vasculopathy in SCD 
remains misunderstood. Today, blood exchange 
transfusions are prescribed for SCD patients with high 
risk, but this conventional treatment has suspensive 
effects. Bone marrow transplants offer the only potential 
cure for SCD but are limited by the number of compatible 
donors (potential human leukocyte antigen-matched 
hematopoietic stem cells)[5]. In the future, gene therapy 
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will offer a new approach to cure SCD. The long-
term goal of this research is to better understand the 
pathophysiology of cerebral arterial disease in SCD and 
possibly to discover or predict the chances of success, 
of new therapeutic approaches. Unfortunately, animal 
models do not allow the analysis of the pathophysiology 
of cerebral vasculopathy because of the huge difference 
between animal and human according to the vessel 
geometry and the hemorheological parameters.
Moreover, in vitro 3D models can allow the analysis of 
extreme conditions that can occur in pathophysiological 
conditions but are difficult to reproduce except in vitro 
conditions. A first step is to develop cell culture on a AM 
vascular geometry for in vitro studies. Actually, there are 
very few methodologies intended to help the designer to 
manufacture a vascular geometry in AM and to perform 
in vitro cell culture on it. As the product is innovative 
and highly multidisciplinary, it is mandatory to answer 
the following research question: Which methodology 
should be used to develop an AM vascular geometry 
designed for cell culture in these in vitro models? This 
paper presents the design approach used to develop 
this experimental product. More generally, this method 
could be applied to all human-based products designed 
for biological purposes using AM. Finally, a use-case is 
proposed to validate the method.
2. Research Objectives and Specifications
In the first part of the project, the aim is to decipher 
the biological pathways involved in the vessel damage 
due to hemorheological pathological conditions found 
in SCD children. Previous work provided shear stress 
abnormalities in the in silico study that should be 
reproduced and analyzed in a 3D model. Thanks to AM, 
the prototype of a vascular geometry can be rapidly 
realized. Then, the effect of sheer stress in a child with 
SCD will be understood. The constraints established by 
the various stakeholders involved in this project are as 
follows: The material must allow to study in vitro the 
interactions between the blood and the endothelium but 
also the impact of pathological speeds of the blood flow 
on the endothelial cells.
3. State-of-The-Art
3.1. Methodologies to Develop Innovative 
Medical Devices
Design of innovative complex products in the medical 
field often involves both engineers and medical experts. 
As innovative medical devices require collaboration 
between multidisciplinary teams, it is important to set up 
a framework to transfer knowledge an efficient between 
those two domains[6]. Arntzen-Bechina and Leguy proposed 
several tools or activities to exchange knowledge, such 
as literature reviews, informal meetings and discussions 
with managers, engineers, researchers, and physicians, 
punctual observations of work practices, and knowledge 
transfer processes[7]. Wong et al. proposed to follow a 
process to manage the engineering and production of 
biomedical devices. The product development strategy 
includes a product conceptualization, a market survey 
and the establishment of strategic alliances, the design, 
prototyping, and product development, the testing and 
commissioning, and technology protection, through 
patents[8].
Bradbury et al. provided an innovative method for rapid 
design, manufacture, and selection of biomedical devices 
such as implants or oral dosage pills using electronic data 
and modeling transmissions through computer networks 
such as the internet, intranets or extranets[9].
A multi-dimensional digital model may be created 
based on radiological data and patient information. 
A collaboration between clinical professionals and 
engineers allows modification of the digital model. Once 
the digital model is approved, it may be converted into 
machine instructions to build the biomedical device. This 
method for rapid construction of biomedical devices 
may be applied to AM. Thus, it is necessary first of all to 
analyze the medical need. Then, the knowledge between 
the medical profession and the engineers is shared 
throughout the project.
3.2. Methodologies to Design Innovative 
Products based on AM
According to Chu et al., the main role of AM technologies 
is to produce “parts and devices that are geometrically 
complex, have graded material compositions, and can 
be customized.” Besides, it is possible to build almost 
any shape with a large range of materials, which could 
be difficult to produce using conventional manufacturing 
methods such as milling, turning, or casting. AM also 
offers fabrication of parts with reduced costs and with 
rapid availability[10].
Bourell et al. advocated to develop new design 
methodologies dedicated to AM: Design for AM 
(DFAM)[11]. The most widespread definition of DFAM is 
a methodology which “maximize product performance 
through the synthesis of shapes, sizes, hierarchical 
structures, and material compositions, subject to the 
capabilities of AM technologies” and “to best utilize 
manufacturing process capabilities to achieve desired 
performance and other life-cycle objectives”[12,13].
Wong and Hernandez presented the general process 
of AM[14]. It is also presented by Noorani in Figure 1. 
It summarizes the stages of product development using 
rapid prototyping and shows that there can be several 
iterations before the final product.
Lenoir L, et al.
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Chu et al. (2008) proposed a method for DFAM, specialized 
in cellular materials, presented in Figure 2. Usually, the 
microstructure of the part is analyzed and examined after 
processing it, to determine its mechanical properties. Here, 
as the material is more complex, the approach consists of 
reversing the process by “specifying desired behavior.
After planning a manufacturing process, the idea 
is that the process will be simulated on the current 
design to determine the as-manufactured shapes, sizes, 
mesostructures, and microstructures. Then manufactured 
model will be analyzed to determine whether or not it 
actually meets design objectives.”
In a multidisciplinary environment, combining 
engineers and health professionals for instance, not only 
the process to produce pieces using AM is important but 
also the way that information, data, and documents are 
shared and managed.
As Ponche et al. resumed in a study, the “partial 
approach” in DFAM consists in starting from an initial 
geometry in a computer-aided design (CAD) model[16].
In general, this geometry is not really designed for an 
AM process: It will be necessary to modify and improve 
it for rapid prototyping. The partial approach thus can be 
used in the case someone has an initial CAD model and 
wants to manufacture it by AM.
The methodology proposed in this study is presented 
in Figure 3. It is divided into three main steps. The first 
step is a global analysis which allows the delimitation of 
the design problem in terms of geometrical dimensions 
in relation to the dimensional characteristics of the 
AM process. The second step allows the fulfillment 
of the dimensional and geometrical specifications in 
relation to the AM process capability and the finishing 
process characteristics. Finally, the third step allows the 
fulfillment of the physical and assembly requirements in 
relation to the capability of the AM process.
In general, a rapid prototyping methodology is 
composed of four phases: Initialization, Design, 
Development/Manufacturing, and Validation. In addition, 
the specifications are defined at the flow rate, as are the 
Figure 1. Product development cycle adapted from Noorani[15].
Figure 2. Design for additive manufacturing system and overall method from Chu et al.[10]
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Figure 3. A proposed design for additive manufacturing methodology (Ponche et al. 2012).
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manufacturing plan and the strategic choices. Finally, the 
different methodologies propose a product improvement 
phase.
3.3. Manufacturing Process of Devices for 
Biological Application
Only methodologies to design and manufacture a 
product for biological application based on an initial 
patient medical imaging exist. Wong et al. suggested 
a framework in five steps (Figure 4): Measurement, 
verification, design evaluation, design modification, 
and finally, design optimization[8]. The first phase is 
based on both in vivo and in vitro measurement to define 
the geometry. Verification is needed by modeling the 
geometry and experimental conditions. Then, the design 
will be evaluated and analyzed: Surfaces of the previous 
medical imaging are rebuilt thanks to a CAD model, and 
flow visualization is generated using different software 
tools. The model can be modified after a clinical testing 
phase that requires medical knowledge. Finally, an 
optimization may start once the product is approved.
Today, polydimethylsiloxane (PDMS) and Flexdym 
are privileged material for cell-culture devices[17,18]. 
Concerning microfluidic devices, Shin et al., reported 
the development of a methodology to create an 
endothelialized network with a vascular geometry in a 
biocompatible polymer, PDMS[19].
Using photolithography, master molds were fabricated 
by etching the network pattern into silicon wafers. Closed 
channels were created from silicon master molds by replica 
molding of PDMS and subsequent plasma-bonding of a 
patterned PDMS template to a flat PDMS sheet.
Usually, laboratories’ chips made of PDMS are 
relatively simple shapes, which can be manufactured by 
stereolithography or equivalents.
However, these techniques are not adapted to produce 
complex geometries. With the recent advances in AM, 
use of PDMS for the fabrication of such complex shapes 
has gained considerable interest.
The results of Ozbolat et al. demonstrated that 3D 
printing of PDMS elastomers is possible and improves 
the mechanical properties of fabricated samples up to 
three-fold compared to that of cast ones. It also facilitates 
the adhesion and the growing[20].
The PDMS is very appreciated for its qualities of 
translucent and rigidity. However, it has many flaws that 
Figure 4. The proposed method by Wong et al. (2013) to produce a health device based on medical imaging.
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prevent it from being marketable on a large scale. However, 
the disadvantages of PDMS are the absorption of small 
molecules, the manufacturing method incompatible with 
mass production and also its reversible hydrophilicity.
Lachaux et al. found a new polymer (Flexdym) offering 
flexibility and translucent comparable to PDMS. Flexdym 
is a copolymer block solution, composed of Di or Triblock 
according to the different grade. It is similarities with the 
PDMS but without the drawbacks. Easy and inexpensive 
microstructuration method, microfluidic devices are 
fabricated in less than a minute[21].
Furthermore, microfabrication can be performed 
using a hot-embossing machine or a very simple press 
equipment; downstream Flexdym is amenable for rapid 
manufacturing technology such as injection molding. 
Flexdym can be bonded easily without surface treatments 
and pressure loads, thanks to is mechanical properties.
Sealing can be achieved either on a simple hot plate or 
even at room temperature. It is flexible and thus allows 
cutting into small pieces. It is translucent and biocompatible 
which will allow the study of cell culture. Due to its 
bonding qualities, two-part molding is envisaged.
Recently, cell culture studies have been released on 
VeroClear, AM material. Lu et al. used Veroclear because 
of its good formation properties and high precision. 
However, the interactions between cells and materials 
are affected by topography and surface chemistry of the 
implant materials, such as roughness and hydrophilic 
properties[22].
In this study, authors have developed a method 
of coating waterborne polyurethane (WPU) onto the 
Veroclear resin to improve the biocompatibility. WPU 
(Safe polymeric material) is a coating material for 
creating barriers between corrosive environments and 
material surfaces. WPU has been used in medical implants 
because of its low toxicity, good biocompatibility, and 
coating characteristics.
3.4. Synthesis
Only a few papers rely on AM to produce biomedical 
parts. This paper highlights existing methodologies for 
designing innovative products based on AM, others that 
can help develop innovative medical devices. However, it 
is difficult to find a methodology that combines these two 
aspects; there are only a few at the intersection of these 
two technologies.
The interesting points of these different methodologies 
are:
• Well understand the goals and needs of the user
• Engineers and health professionals pool their
knowledge throughout the project
• Strategic choice and plan of manufacturing before
prototyping
• Design by performing user tests
• Optimization of the product with iterations
• Final validation
• Make sure the product is correctly used
• Tests prototype and medical return to improve the
model.
Thus, in this article, an innovative methodology 
to achieve a complex vascular geometry using AM 
is proposed. As mentioned before, there are few 
methodologies that combine the realization of medical 
devices and AM processes. Existing methodologies do 
not propose to simplify the complex geometry to allow 
faster validation of all subsequent steps such as the choice 
of material or the cellular study. Here, we can proceed 
with iteration loops and improve our design each time 
to finally fulfill the complex form. Thus, the proposed 
method can be adapted to any case study.
4. A Methodology to Develop Vascular
Geometry for In Vitro Cell Culture using
AM: AM-Biopart
The proposed method (Figure 5) is based on important 
points told in the synthesis that chosen from the existing 
methods seen previously.
The method proposed by Lenoir et al. (2019) is 
divided into four steps. The first “Initialization” consists 
of understanding and summarizing the objectives, needs, 
and constraints desired by the medical profession. 
Knowledge is capitalized and well transferred between 
engineers and health professionals.
Then, Step II, “concept and feasibility” allow to search 
and define the different manufacturing methods and then 
to know their costs.
For Step III, “design and development” is more 
complex. Geometry simplification strategy is included 
(Step III, 1) to allow engineers to focus first on the 
material to be used that meets the different constraints.
Once these parameters have been approved (Step III, 8), 
the geometry can be made more complex (Step III, 9). 
Then, the whole process can start again (Steps III, 2) to 
(Steps III, 7), through an improvement of the design, until 
the final validation of the realistic 3D model.
Finally, during the last step, the design is optimized 
by performing user tests. At the end, once everything is 
validated and optimized, only training for clinical use 
remains.
5. Use Case AM-Biopart Adapted to the
Manufacturing of a Carotid
In this section, the method is tested on the manufacturing 
of a carotid (Figure 6) in vitro to understand the 
physiopathology.
This carotid was modeled by ARM (Figure 7), on 
a sickle cell child. ARM is an exam that specifically 
Lenoir L, et al.
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addresses the body’s vessels, arteries, and veins, often 
better visualized after injection, of a product[25].
The focus is made on Step III “design and development”:
1. Idea of simplified geometry
The carotid geometry have a very complex form
that is why it bring back to a simplified form. The
complex geometry is changed in a tube of 50 mm
length and 4 mm internal diameter. With each side
connectors for the pump (Figure 7).
The simplification of the model has been established
by engineers and biological researchers. It consists of
bringing the complex model back to a simple shape,
here a tube. Thus, this simplified geometry will make
it possible to validate as quickly as possible all the
elements on the cellular culture part as well as the
manufacturing method of the tube. Finally, once
everything is approved, a new iteration is performed
with more complex geometry.
2. CAD design
Achievements of several CAD with CATIA software
(Figure 8) show a half-mold for casting.
3. Criteria related to process and the material
After the CAD, it is necessary to choose the process
and the material to use. Here, the molds are made
in AM with a material called acrylonitrile butadiene
styrene, which is a thermoplastic polymer having
good impact strength, relatively rigid, lightweight,
and moldable. Then, the PDMS was cast; the result is
shown in Figure 9.
4. In vitro cell-culture testing on prototypes and testing
under flow conditions
PDMS has been tested in cell culture and inflow
conditions, using a pump that can send large flows.
During flow cell culture development, the prototype
and manufacturing of PDMS tube were ameliorated
to optimize la perfusion at high flow and observation
on microscopy.
Figure 7. Simplification of the carotid geometry.
Figure 8. Half-mold for casting.
Figure 6. Branches of the internal carotid artery (A) lateral view 
(B) anteroposterior view (PEACE 2017)[24].
A B
Figure 5. Proposed method additive manufacturing-Biopart by Lenoir et al.[23]
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5. Observation and biologist Feedback
Human umbilical vein endothelial cells (HUVECs)
were seeded in a tube fabricated by two-half mold
technique. After 2 h of static culture, a homogenous
monolayer with confluence was observed (Figure 10). 
A weak flow rate perfusion (Figure 11, shear stress 1 
dyn/cm²) was then applicated on cells for 3H following 
by immunostaining to visualize specific markers of 
endothelial cells (PECAM-1, Platelet endothelial cell 
adhesion molecule 1) and their nuclear (DAPI). The 
results demonstrated that HUVECs monolayer was 
still confluence (Figure 12).
As flow experiments in artificial carotid will be 
performed at high shear stress, HUVECs monolayer 
was challenged with flow culture at high flow rate 
perfusion (shear stress 6.5 dyn/cm²). However, the assay 
was stopped after 12 min because of medium leaking at 
bonding site on the two-half tube. Moreover, on phase-
contrast microscopy, cells detachments were found in 
many areas (Figure 13).
Figure 9. Polydimethylsiloxane cast in two parts in mold 
printed in 3D.
Figure 11. Experimental of blood flow in a polydimethylsiloxane 
molded carotid (100 mL/min).
Figure 10. Human umbilical vein endothelial cells after 2 h of 
static culture.
Figure 12. Human umbilical vein endothelial cells (HUVECs) 
culture with weak flow rate perfusion. Immunostaining of platelet 
endothelial cell adhesion molecule-(green, a membrane specific 
marker of HUVECs) and nuclei (DAPI, blue).
Figure 13. Human umbilical vein endothelial cells culture with 
high flow rate perfusion.
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Therefore, to reach the objective of flow experiment 
in carotid, molding technique, and cells resistance under 
high shear stress must be improved.
6. Conclusion and Future Work
In this paper, a global framework of design approach 
focused on AM to develop vascular geometry is proposed. 
It can be applied to all human-based products designed 
for biological purposes using AM. The main research 
question of this article is: Which methodology should be 
used to develop an AM vascular geometry designed for 
cell culture in these in vitro models?
The proposed AM-Biopart methodology takes 
place in four stages with initialization, concept and 
feasibility, design and development, and finally 
validation and optimization. This allows us to have a 
common thread for people wishing to achieve vascular 
geometry in AM, with the collaboration of different 
trades. The proposed method has been successfully 
applied to the design of a carotid artery. However, for 
later if we want to guarantee a fully optimized part, 
some process parameters, such as the choice of laser 
power, scanning speed, and hatch spacing, must be 
taken into account in the process. Future work will 
involve testing the proposed methodology on a more 
complex case study.
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